FCI Ophthalmics

What FCI Ophthalmics does

FCI Ophthalmics, Inc. (FCI/ZEISS) is a Massachusetts-incorporated medical device company founded in 1984 that develops and manufactures specialized ophthalmic surgical devices. The company operates as a wholly-owned subsidiary of ZEISS Group (a diversified conglomerate operating cross-border through legally independent companies) and is managed alongside FCI Worldwide (international markets) and FCI France under a unified FCI/ZEISS corporate identity announced in 2022. Headquartered in Pembroke, MA, FCI Ophthalmics serves US and Canadian markets, with global reach coordinated through its sister entities.

The company's product portfolio spans six surgical categories: lacrimal stents and tubes (including the LacriJet preloaded monocanalicular intubation and StopLoss Jones Tubes), oculoplastics and eyelid repair (OCULID gold/platinum eyelid weights, Ptose-Up, FCI PROLONG plugs), orbital implants (EZYPOR porous polyethylene and bioceramic implants), cataract surgery devices (MORCHER capsular tension rings, Mackool hooks, GEMCISION sapphire knives, Kitaro kits), vitreoretinal instruments (RetiLock trocar cannulas, MULTIFLEX directional laser probes, vitrectomy lenses, silicone bands/tires/sponges), and dry eye products (SnugPlug, FCI PROLONG). Differentiated, patented technologies include RetiLock's scleral ring stabilization system, MULTIFLEX's 19 Ga telescoping stiffening sleeve, the first-mover LacriJet preloaded monocanalicular system, and GEMCISION's resposable sapphire blades positioned as a cost-effective alternative to diamond and stainless steel. The product range is designed largely by or in collaboration with practicing surgeons such as Richard J. Mackool, M.D. and others.

FCI generates revenue through B2B direct sales of medical devices to ophthalmic surgeons, hospitals, ambulatory surgery centers, and eye clinics, with pricing provided via quote upon request and no public pricing disclosure. Distribution channels include a US/Canada direct sales team (reachable via 800-932-4202), FCI Worldwide for international markets, and FCI France. Marketing is concentrated around professional industry conferences (AAO, ASOPRS), a LinkedIn and YouTube presence, and digital catalogs/clinical resources. The company qualifies under a single customer segment of healthcare providers, with horizontal segmentation across surgical sub-specialties. No AI/ML, software, or data-driven product components are documented, and the company's AI maturity appears to be effectively none.

Name

FCI Ophthalmics

Legal name

FCI Ophthalmics Inc.

Website

https://fci-ophthalmics.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

51–100 employees

Short description

FCI Ophthalmics, a ZEISS Group subsidiary founded in 1984 and headquartered in Pembroke, MA, designs and manufactures specialized ophthalmic surgical devices across lacrimal, eyelid, orbital, cataract, vitreoretinal, and dry eye categories, selling direct to surgeons, hospitals, and ambulatory surgery centers in the US, Canada, and globally.

Ownership category

akta.pro rank

Product category

Ophthalmic Surgical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Ophthalmic Goods Manufacturing (339115)

SIC

Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851)

akta.pro primary industry

Oculoplastics & Lacrimal Surgical Devices (Ptosis/Orbital Tools, DCR/Lacrimal Stents, Facial Implants) (HLAHAJAL)

akta.pro secondary industries

Vitreoretinal Surgical Devices (Vitrectomy Systems, Endolaser, Illumination, Tamponades) (HLAHAJAJ), Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH), Ocular Drug Delivery Devices (Eye Droppers/Inserts) (HLAHAIAL)

Keywords

• Ophthalmic surgical devices
• Lacrimal stents
• Orbital implants
• Cataract surgery instruments
• Vitreoretinal instruments

Headquarters

HQ city

Pembroke

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Ophthalmic Surgical Devices: FCI Ophthalmics generates revenue through the manufacturing and sale of specialized ophthalmic surgical devices including lacrimal stents, eyelid implants, orbital implants, cataract devices, vitreoretinal instruments, and dry eye products to healthcare providers worldwide.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

FCI Ophthalmics manufactures and distributes ophthalmic surgical devices used by eye surgeons and healthcare facilities. Its portfolio includes lacrimal stents (e.g., Jones tubes), eyelid and orbital implants, cataract surgery devices, vitreoretinal instruments, and dry eye products such as punctal plugs. The company sells its branded devices to ophthalmologists, hospitals, and ambulatory surgery centers worldwide.

Product overview

FCI Ophthalmics is a world leader in ophthalmic surgical devices since 1984, operating as a subsidiary of ZEISS. The company offers a comprehensive portfolio of surgical devices across multiple categories: lacrimal stents and tubes (including LacriJet® monocanalicular intubation and StopLoss® Jones Tubes), oculoplastics (eyelid implants and weights such as OCULID® and Ptose-Up for lagophthalmos and ptosis), orbital implants (EZYPOR® porous polyethylene and bioceramic implants), cataract surgery devices (capsular tension rings, Mackool™ hooks, GEMCISION™ sapphire knives, titanium instruments), vitreoretinal products (laser probes, vitrectomy lenses, RetiLock® trocar cannulas, scleral buckles including bands/tires/sponges), and dry eye treatments (SNUGPLUG® and PROLONG® punctal plugs). The portfolio includes both proprietary branded products and distributed products from manufacturers like MORCHER® (CTR) and Katalyst.

Differentiator

Problem solved

Functional benefit

Brands

• LacriJet: The First Preloaded & Self-Retaining Monocanalicular Nasolacrimal Intubation device.
• StopLoss
• OCULID
• EZYPOR
• GEMCISION
• SnugPlug
• RetiLock
• Kitaro

Products and services

• LacriJet Preloaded self-retaining monocanalicular nasolacrimal intubation stent used in dacryocystorhinostomy (DCR) and canalicular laceration repair procedures. Designed for ophthalmic surgeons treating tear duct obstructions.
• StopLoss Jones tube used in lacrimal bypass surgery to relieve tearing caused by canalicular obstruction. Targeted at oculoplastic surgeons performing conjunctivodacryocystorhinostomy (CDCR).
• OCULID Eyelid weight implant used to treat lagophthalmos (incomplete eyelid closure), commonly associated with facial paralysis. Sold to ophthalmologists and oculoplastic surgeons.
• EZYPOR Bioceramic orbital implant used in enucleation and evisceration procedures following eye removal. Targeted at ophthalmic surgeons performing anophthalmic socket reconstruction.
• GEMCISION Preloaded lens delivery system for cataract surgery, combining injector and intraocular lens (IOL) in a single-use device for small-incision cataract procedures.
• SnugPlug Punctal plug used to treat dry eye syndrome by blocking tear drainage to retain natural tears on the ocular surface. Designed for ophthalmologists managing dry eye patients.
• RetiLock Vitreoretinal surgical instrument used in retinal detachment and posterior segment surgery. Sold to vitreoretinal surgeons.
• Kitaro Vitreoretinal instrumentation used in posterior segment ophthalmic surgery. Targeted at retinal specialists performing vitreoretinal procedures.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Morcher GmbH: German developer of capsular tension rings and IOL-related cataract surgery devices (now part of ZEISS group), already a distributing partner per FCI's catalog and a direct peer in cataract surgery accessories.
• Geuder AG: German ophthalmic surgical device specialist with comparable heritage and a portfolio spanning vitreoretinal, cataract, and oculoplastic instruments, closely mirroring FCI's European positioning.
• Katena Products: Independent ophthalmic surgical instrument and disposable manufacturer serving oculoplastic, cataract, and vitreoretinal surgeons — directly comparable mid-sized peer to FCI in product breadth and surgeon customer base.
• New World Medical: Ophthalmic surgical device company focused on glaucoma and oculoplastic implants, directly overlapping with FCI's orbital and oculoplastic surgical franchise.
• Beaver-Visitec International (BVI): Specialized manufacturer of ophthalmic surgical instruments, knives, and disposables including blades and cannulas that compete directly with FCI's GEMCISION sapphire knives and RetiLock trocar systems.
• Asico: US-based manufacturer of ophthalmic surgical instruments and devices for cataract and vitreoretinal surgery, with a similar mid-sized private operating profile targeting the same surgical specialist customers.
• Rhein Medical: Specialty manufacturer of ophthalmic surgical hand instruments and knives used in cataract and vitreoretinal surgery, competing with FCI's titanium instruments and sapphire blades.
• Surgical Specialties Corporation: Manufacturer of specialty surgical knives and ophthalmic micro-surgical instruments that compete with FCI's GEMCISION sapphire knife line in cataract and scleral buckle procedures.

Broad incumbents

• Alcon: Global leader in ophthalmic surgery with broad vitreoretinal, cataract, and oculoplastic offerings; many of FCI's laser probes and vitrectomy accessories are explicitly compatible with Alcon surgical platforms.
• Bausch + Lomb: Diversified ophthalmic manufacturer with extensive surgical instrument and IOL portfolios that directly overlap with FCI's cataract and vitreoretinal product categories, competing for the same hospital procurement budgets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xtwitter.com/FCI_Ophthalmics
• YouTubeyoutube.com/c/fciophth
• LinkedInlinkedin.com/company/fci-ophthalmics
• Instagraminstagram.com/fci_ophthalmics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FCI Ophthalmics